OJeanson A, Nielsen E, Friberg L
JAC Antimicrob Resist. 2025; 7(2):dlaf036.
PMID: 40070893
PMC: 11894798.
DOI: 10.1093/jacamr/dlaf036.
Alikhani M, Nazari M, Hatamkhani S
Front Cell Infect Microbiol. 2025; 15:1521091.
PMID: 40070375
PMC: 11893874.
DOI: 10.3389/fcimb.2025.1521091.
Kong D, Roberts J, Lipman J, Taccone F, Cohen-Wolkowiez M, Sime F
Clin Pharmacokinet. 2024; 64(1):107-126.
PMID: 39722108
PMC: 11762590.
DOI: 10.1007/s40262-024-01460-6.
Boutzoukas A, Balevic S, Hemmersbach-Miller M, Winokur P, Gu K, Chan A
Clin Pharmacokinet. 2024; 64(2):229-241.
PMID: 39681779
DOI: 10.1007/s40262-024-01465-1.
Hernandez-Lozano I, Aranzana-Climent V, Cao S, Matias C, Ulf Hansen J, Liepinsh E
J Antimicrob Chemother. 2024; 80(1):301-310.
PMID: 39548844
PMC: 11695905.
DOI: 10.1093/jac/dkae409.
Free serum concentrations of antibiotics determined by ultrafiltration: extensive evaluation of experimental variables.
Lier C, Dejaco A, Kratzer A, Kees M, Kees F, Dorn C
Bioanalysis. 2024; 16(14):747-756.
PMID: 39041640
PMC: 11389746.
DOI: 10.1080/17576180.2024.2365526.
Towards pharmacokinetic boosting of phenoxymethylpenicillin (penicillin-V) using probenecid for the treatment of bacterial infections.
Wilson R, Riezk A, Arkell P, Ming D, Armiger R, Latham V
Sci Rep. 2024; 14(1):16762.
PMID: 39034340
PMC: 11271292.
DOI: 10.1038/s41598-024-67354-6.
In Vitro Antibacterial Activities of Fosfomycin against Isolates from Canine Urinary Tract Infection.
Jariyapamornkoon N, Nuanualsuwan S, Suanpairintr N
Animals (Basel). 2024; 14(13).
PMID: 38998027
PMC: 11240368.
DOI: 10.3390/ani14131916.
Optimizing Antibiotic Therapy for Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach.
Barrasa H, Moran M, Fernandez-Ciriza L, Isla A, Solinis M, Canut-Blasco A
Antibiotics (Basel). 2024; 13(6).
PMID: 38927219
PMC: 11201243.
DOI: 10.3390/antibiotics13060553.
Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations.
Bentley D
Antibiotics (Basel). 2024; 13(4).
PMID: 38667012
PMC: 11047560.
DOI: 10.3390/antibiotics13040337.
Population Pharmacokinetic Model of Linezolid and Probability of Target Attainment in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation-A Step toward Correct Dosing.
Milakovic D, Kovacevic T, Kovacevic P, Barisic V, Avram S, Dragic S
Pharmaceutics. 2024; 16(2).
PMID: 38399307
PMC: 10892643.
DOI: 10.3390/pharmaceutics16020253.
In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and/or Trimethoprim-Sulfamethoxazole-Resistant .
Wu J, Zhang G, Zhao Q, Wang L, Yang J, Cui J
Infect Drug Resist. 2023; 16:6005-6015.
PMID: 37705512
PMC: 10497097.
DOI: 10.2147/IDR.S425061.
Rapid In Vitro Assessment of Antimicrobial Drug Effect Bridging Clinically Relevant Pharmacokinetics: A Comprehensive Methodology.
Nikolaou M, Tam V
Pharmaceutics. 2023; 15(6).
PMID: 37376120
PMC: 10305065.
DOI: 10.3390/pharmaceutics15061671.
Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?.
Rodriguez-Gascon A, Alarcia-Lacalle A, Solinis M, Del Pozo-Rodriguez A, Abajo Z, Cabero M
Pharmaceutics. 2023; 15(4).
PMID: 37111669
PMC: 10144240.
DOI: 10.3390/pharmaceutics15041185.
Pharmacokinetics and Pharmacodynamics of Florfenicol in Plasma and Synovial Fluid of Pigs at a Dose of 30 mg/kg Following Intramuscular Administration.
Somogyi Z, Mag P, Simon R, Kerek A, Szabo P, Albert E
Antibiotics (Basel). 2023; 12(4).
PMID: 37107120
PMC: 10135420.
DOI: 10.3390/antibiotics12040758.
Biased computation of probability of target attainment for antimicrobial drugs.
Toutain P, Gandia P, Pelligand L, Ferran A, Lees P, Bousquet-Melou A
CPT Pharmacometrics Syst Pharmacol. 2023; 12(5):681-689.
PMID: 37025064
PMC: 10196429.
DOI: 10.1002/psp4.12929.
Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients-A Narrative Review.
Stasek J, Keller F, Koci V, Klucka J, Klabusayova E, Wiewiorka O
Antibiotics (Basel). 2023; 12(3).
PMID: 36978435
PMC: 10044408.
DOI: 10.3390/antibiotics12030568.
Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients.
Martinez-Casanova J, Esteve-Pitarch E, Colom-Codina H, Gumucio-Sanguino V, Cobo-Sacristan S, Shaw E
Antibiotics (Basel). 2023; 12(3).
PMID: 36978398
PMC: 10044067.
DOI: 10.3390/antibiotics12030531.
Beta-Lactam Probability of Target Attainment Success: Cefepime as a Case Study.
Selig D, Kress A, Nadeau R, DeLuca J
Antibiotics (Basel). 2023; 12(3).
PMID: 36978312
PMC: 10044207.
DOI: 10.3390/antibiotics12030444.
Safety and Tolerability of Antimicrobial Agents in the Older Patient.
Soraci L, Cherubini A, Paoletti L, Filippelli G, Luciani F, Lagana P
Drugs Aging. 2023; 40(6):499-526.
PMID: 36976501
PMC: 10043546.
DOI: 10.1007/s40266-023-01019-3.
